Victory Capital Management’s CAMP4 Therapeutics CAMP Stock Holding History

Victory Capital Management’s Portfolio CAMP Stock Details CAMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$360K	Hold	82,450	–	–	﹤0.01%	2132
2026 Q1	$364K	Sell	82,450 -340	-0.4%	-$1.61K	﹤0.01%	2091
2025 Q4	$508K	Hold	82,790	–	–	﹤0.01%	2015
2025 Q3	$248K	Sell	82,790 -270	-0.3%	-$500	﹤0.01%	2180
2025 Q2	$120K	Buy	83,060 +1,330	+2%	+$2.65K	﹤0.01%	2310
2025 Q1	$327K	Buy	81,730 +19,430	+31%	+$94K	﹤0.01%	2122
2024 Q4	$325K	Buy	+62,300	New	+$512K	﹤0.01%	2131

Other funds holding CAMP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Victory Capital Management's CAMP Position: Q2 2026 in Review

Victory Capital Management held its CAMP4 Therapeutics (CAMP) position steady in Q2 2026 at 82,450 shares worth $360K. The position accounts for ﹤0.01% of the portfolio, ranked #2132.

Victory Capital Management first reported a position in CAMP in Q4 2024 and has held it in 7 quarters since. The position peaked at $508K in Q4 2025. 16 funds tracked by Wall St. Rank hold CAMP as of Q2 2026.

Victory Capital Management held 82,450 shares of CAMP4 Therapeutics worth $360K as of Q2 2026.
Victory Capital Management left its CAMP4 Therapeutics share count unchanged in Q2 2026.
CAMP4 Therapeutics made up ﹤0.01% of Victory Capital Management's portfolio in Q2 2026, its #2132 holding.
Victory Capital Management first reported a position in CAMP4 Therapeutics in Q4 2024 and has held it in 7 quarters since.
Victory Capital Management's CAMP4 Therapeutics position peaked at $508K in Q4 2025.
16 funds tracked by Wall St. Rank held CAMP4 Therapeutics as of Q2 2026.

Based on Victory Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.